openPR Logo
Press release

Optical Genome Mapping Market Size, Share, Trend Analysis, Segmentation And Forecast To 2033

Optical Genome Mapping Market

Optical Genome Mapping Market

"The new report published by The Business Research Company, titled ""Optical Genome Mapping Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the optical genome mapping market size has grown exponentially in recent years. It will grow from $0.14 billion in 2023 to $0.17 billion in 2024 at a compound annual growth rate (CAGR) of 29.4%. The optical genome mapping market size is expected to see exponential growth in the next few years. It will grow to $0.49 billion in 2028 at a compound annual growth rate (CAGR) of 29.5%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15882&type=smp

Precision Medicine Driving Growth In The Optical Genome Mapping Market
The increasing demand for precision medicine is expected to propel the growth of the optical genome mapping market going forward. Precision medicine is an approach to healthcare that customizes medical treatment and prevention strategies to individual characteristics such as genetic makeup, lifestyle, and environment. Precision medicine demand is driven by the rising prevalence of chronic diseases, advancements in genomic technologies, increasing investment and funding, and patient demand for personalized care. optical genome mapping enhances the capabilities of precision medicine by providing a detailed and accurate understanding of the genomic alterations associated with various diseases. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Therefore, the increasing demand for precision medicine is driving the growth of the optical genome mapping market.

Development Of Optical Genome Mapping-Based LDTs For Enhanced Diagnostic Capabilities
Major companies operating in the optical genome mapping market are developing optical genome mapping-based laboratory-developed tests (LDT) to enhance diagnostic capabilities and offer more accurate genomic insights. Optical genome mapping-based laboratory-developed tests (LDTs) are diagnostic assays designed and implemented within individual clinical laboratories using optical genome mapping (OGM) technology. For instance, in September 2022, Bionano Genomics Inc., a US-based company providing genome analysis software, launched optical genome mapping-based LDT for facioscapulohumeral muscular dystrophy (FSHD). The OGM-based LDT will enable Bionano Laboratories to offer services to customers seeking to implement OGM into their diagnostic routines and for research applications with hospitals, pharmaceutical companies, and other parties.

The optical genome mapping market covered in this report is segmented -

1) By Product: Instruments, Consumables And Reagents, Software, Services
2) By Application: Structural Variant Detection, Genome Assembly, Microbial Strain Typing, Other Applications
3) By End-User: Biotechnology And Pharmaceutical Companies, Clinical Laboratories, Academic Research Institutes, Other End-Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=15882&type=discount

Major companies operating in the optical genome mapping market are Agilent Technologies Inc., Illumina Inc., PerkinElmer Genomics, Bio-Rad Laboratories Inc., Qiagen N.V., Cerba Healthcare, GenScript Biotech Corporation, 10x Genomics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., NanoString Technologies Inc., MedGenome, Element Biosciences, Bionano Genomics Inc. , Stratos Genomics, BioSkryb Genomics, Source Genomics, Genoox, Nucleome Informatics Private Limited, Praxis Genomics LLC, Phase Genomics Inc., Daicel Arbor Biosciences, Nabsys, OpGen, Genohub Inc.

Contents of the report:
1. Executive Summary
2. Optical Genome Mapping Market Report Structure
3. Optical Genome Mapping Market Trends And Strategies
4. Optical Genome Mapping Market - Macro Economic Scenario
5. Optical Genome Mapping Market Size And Growth
…..
27. Optical Genome Mapping Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/optical-genome-mapping-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Optical Genome Mapping Market Size, Share, Trend Analysis, Segmentation And Forecast To 2033 here

News-ID: 3583488 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Genome

Emerging Trends Influencing The Growth Of The Genome Editing/Genome Engineering …
The Genome Editing/Genome Engineering Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Genome Editing/Genome Engineering Market Size Expected to Be by 2034? The size of the genome editing/genome engineering market has expanded swiftly in the past few years. Forecasts suggest the growth
Genome Editing/Genome Engineering Market 2023 - Size, Share, Segments, Data, Gro …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 Genome Editing Or Genome Engineering Market Size, Growth Rate, And Forecast The global genome editing or genome engineering market size is expected to grow from $6.11 billion in 2022 to $7.20 billion in 2023 at a compound annual growth rate (CAGR) of 17.8%. The genome editing or genome
Genome Editing & Genome Engineering Industry Research Report, Growth, Trends 202 …
Genome Editing & Genome Engineering Market 2028 Genome editing technology refers to the ability of human to "edit" the target gene, such as the deletion and addition of specific DNA fragments. Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Genome Editing & Genome Engineering estimated at US$ 3953 million in the year 2022, is projected to reach a revised size of US$ 6739.8 million by 2028,
Genome Editing/Genome Engineering Market Size - Industry Analysis Report 2021
Genome Editing/Genome Engineering Market Size, Capacity, Trends, Outlook, Research, Analysis, Growth | Industry Report 2021 Market Research Report to It’s a Database. Inquire Before Buying @ http://bit.ly/2uh3G7k The genome editing market is projected to reach USD 5.54 billion by 2021 from USD 2.84 billion in 2016, growing at a CAGR of 14.3% in the next five years (2016 to 2021). The genome editing market is undergoing a significant transformation, with the
Genome Editing/Genome Engineering Market to experience hike in growth by 2024
Zion Market Research, the market research group announced the analysis report titled ‘Genome Editing/Genome Engineering Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024’ Global Genome Editing/Genome Engineering Market: Overview Genome editing/genome engineering refers to the techniques and strategies in which the DNA is deleted, replaced or inserted in the living organism’s genome with the help of molecular scissors or engineered nucleases. It is one of the active fields of
Global Genome Editing/Genome Engineering Market Size, Status and Forecast 2022
Qyresearchreports include new market research report "Global Genome Editing/Genome Engineering Market Size, Status and Forecast 2022" to its huge collection of research reports. The term healthcare has held a consistent definition over the many years of its development so far. However, the point at which this industry resides now is extremely advanced than the point it was at a few decades ago, thanks to the recent boom in technological advancements, the